Leah M Backhus1, Farhood Farjah2, Chao-Kang Jason Liang3, Hao He2, Thomas K Varghese2, David H Au4, David R Flum2, Steven B Zeliadt5. 1. Surgery Service, VA Palo Alto Health Care System, Palo Alto, California; Department of Cardiothoracic Surgery, Stanford University, Stanford, California. Electronic address: lbackhus@stanford.edu. 2. Department of Surgery, University of Washington, Seattle, Washington. 3. Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington. 4. Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington; Division of Pulmonary and Critical Care, Department of Medicine, University of Washington, Seattle, Washington. 5. Department of Biostatistics, School of Public Health, University of Washington, Seattle, Washington; Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington.
Abstract
INTRODUCTION: The importance of imaging surveillance after treatment for lung cancer is not well characterized. We examined the association between initial guideline recommended imaging surveillance and survival among early-stage resected non-small-cell lung cancer (NSCLC) patients. METHODS: A retrospective study was conducted using Surveillance, Epidemiology, and End Results-Medicare data (1995-2010). Surgically resected patients, with stage I and II NSCLC, were categorized by imaging received during the initial surveillance period (4-8 mo) after surgery. Primary outcome was overall survival. Secondary treatment interventions were examined as intermediary outcomes. RESULTS: Most (88%) patients had at least one outpatient clinic visit, and 24% received an initial computerized tomography (CT) during the first surveillance period. Five-year survival by initial surveillance imaging was 61% for CT, 58% for chest radiography, and 60% for no imaging. After adjustment, initial CT was not associated with improved overall survival (hazard ratio [HR], 1.04; 95% confidence interval [CI] 0.96-1.14). On subgroup analysis, restricted to patients with demonstrated initial postoperative follow-up, CT was associated with a lower overall risk of death for stage I patients (HR, 0.85; 95% CI, 0.74-0.98), but not for stage II (HR, 1.01; 95% CI, 0.71-1.42). There was no significant difference in rates of secondary interventions predicted by type of initial imaging surveillance. CONCLUSIONS: Initial surveillance CT is not associated with improved overall or lung cancer-specific survival among early-stage NSCLC patients undergoing surgical resection. Stage I patients with early follow-up may represent a subpopulation that benefits from initial surveillance although this may be influenced by healthy patient selection bias. Published by Elsevier Inc.
INTRODUCTION: The importance of imaging surveillance after treatment for lung cancer is not well characterized. We examined the association between initial guideline recommended imaging surveillance and survival among early-stage resected non-small-cell lung cancer (NSCLC) patients. METHODS: A retrospective study was conducted using Surveillance, Epidemiology, and End Results-Medicare data (1995-2010). Surgically resected patients, with stage I and II NSCLC, were categorized by imaging received during the initial surveillance period (4-8 mo) after surgery. Primary outcome was overall survival. Secondary treatment interventions were examined as intermediary outcomes. RESULTS: Most (88%) patients had at least one outpatient clinic visit, and 24% received an initial computerized tomography (CT) during the first surveillance period. Five-year survival by initial surveillance imaging was 61% for CT, 58% for chest radiography, and 60% for no imaging. After adjustment, initial CT was not associated with improved overall survival (hazard ratio [HR], 1.04; 95% confidence interval [CI] 0.96-1.14). On subgroup analysis, restricted to patients with demonstrated initial postoperative follow-up, CT was associated with a lower overall risk of death for stage I patients (HR, 0.85; 95% CI, 0.74-0.98), but not for stage II (HR, 1.01; 95% CI, 0.71-1.42). There was no significant difference in rates of secondary interventions predicted by type of initial imaging surveillance. CONCLUSIONS: Initial surveillance CT is not associated with improved overall or lung cancer-specific survival among early-stage NSCLCpatients undergoing surgical resection. Stage I patients with early follow-up may represent a subpopulation that benefits from initial surveillance although this may be influenced by healthy patient selection bias. Published by Elsevier Inc.
Entities:
Keywords:
Cancer follow-up; Guidelines; Imaging surveillance; Lung cancer survival
Authors: Hiroshi Sugimura; Francis C Nichols; Ping Yang; Mark S Allen; Stephen D Cassivi; Claude Deschamps; Brent A Williams; Peter C Pairolero Journal: Ann Thorac Surg Date: 2007-02 Impact factor: 4.330
Authors: Robert J Korst; Heather T Gold; Michael S Kent; Jeffrey L Port; Paul C Lee; Nasser K Altorki Journal: J Thorac Cardiovasc Surg Date: 2005-03 Impact factor: 5.209
Authors: Traves D Crabtree; Varun Puri; Simon B Chen; David S Gierada; Jennifer M Bell; Stephen Broderick; A Sasha Krupnick; Daniel Kreisel; G Alexander Patterson; Bryan F Meyers Journal: J Thorac Cardiovasc Surg Date: 2014-08-08 Impact factor: 5.209
Authors: Catherine Byrd; Ureka Ajawara; Ryan Laundry; John Radin; Prasha Bhandari; Ann Leung; Summer Han; Stephen M Asch; Steven Zeliadt; Alex H S Harris; Leah Backhus Journal: BMC Med Inform Decis Mak Date: 2022-06-03 Impact factor: 3.298
Authors: Hannes Halldorsson; Andri Wilberg Orrason; Gudrun Nina Oskarsdottir; Astridur Petursdottir; Bjorn Mar Fridriksson; Magnus Karl Magnusson; Steinn Jonsson; Tomas Gudbjartsson Journal: Ann Transl Med Date: 2019-03